OncoCyte Corp (OCX)
2.67
-0.08
(-2.91%)
USD |
NASDAQ |
Nov 21, 16:00
2.65
-0.02
(-0.75%)
Pre-Market: 20:00
OncoCyte Market Cap: 44.95M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 44.95M |
| November 20, 2024 | 46.30M |
| November 19, 2024 | 42.93M |
| November 18, 2024 | 44.28M |
| November 15, 2024 | 43.94M |
| November 14, 2024 | 47.14M |
| November 13, 2024 | 49.50M |
| November 12, 2024 | 50.51M |
| November 11, 2024 | 48.82M |
| November 08, 2024 | 48.15M |
| November 07, 2024 | 47.81M |
| November 06, 2024 | 47.81M |
| November 05, 2024 | 49.16M |
| November 04, 2024 | 48.82M |
| November 01, 2024 | 50.51M |
| October 31, 2024 | 51.01M |
| October 30, 2024 | 50.84M |
| October 29, 2024 | 52.19M |
| October 28, 2024 | 52.19M |
| October 25, 2024 | 51.18M |
| October 24, 2024 | 51.35M |
| October 23, 2024 | 53.03M |
| October 22, 2024 | 51.85M |
| October 21, 2024 | 52.53M |
| October 18, 2024 | 52.69M |
| Date | Value |
|---|---|
| October 17, 2024 | 52.53M |
| October 16, 2024 | 52.36M |
| October 15, 2024 | 52.53M |
| October 14, 2024 | 52.53M |
| October 11, 2024 | 51.35M |
| October 10, 2024 | 52.19M |
| October 09, 2024 | 51.68M |
| October 08, 2024 | 51.18M |
| October 07, 2024 | 50.67M |
| October 04, 2024 | 48.65M |
| October 03, 2024 | 39.85M |
| October 02, 2024 | 40.79M |
| October 01, 2024 | 39.99M |
| September 30, 2024 | 38.12M |
| September 27, 2024 | 38.52M |
| September 26, 2024 | 39.72M |
| September 25, 2024 | 39.19M |
| September 24, 2024 | 40.12M |
| September 23, 2024 | 42.13M |
| September 20, 2024 | 44.67M |
| September 19, 2024 | 40.12M |
| September 18, 2024 | 39.45M |
| September 17, 2024 | 41.59M |
| September 16, 2024 | 42.13M |
| September 13, 2024 | 41.17M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
17.18M
Minimum
Nov 08 2023
569.45M
Maximum
Feb 16 2021
141.03M
Average
101.19M
Median
Market Cap Benchmarks
| Fonar Corp | 105.27M |
| XWELL Inc | 7.603M |
| ProPhase Labs Inc | 18.55M |
| Applied DNA Sciences Inc | 1.630M |
| Veracyte Inc | 3.018B |
Market Cap Related Metrics
| PS Ratio | 40.59 |
| Price to Book Value | 4.629 |
| Price | 2.67 |
| Earnings Yield | -170.0% |